InvestorsHub Logo
Followers 1054
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Thursday, 08/02/2018 8:36:06 AM

Thursday, August 02, 2018 8:36:06 AM

Post# of 7536
TEVA $241M net lose ( GAAP). gross profit reduced sharply, By 27%. Another red flag is TEVA's flag product Copaxone. Sales collapsed by 46%. I recommended it at around $17, but recently warned about it's future: ash: "TEVA Bonds - real concern. Moody’s Downgrades Teva Bond Rating to “Junk”. Teva’s Credit Rating also Cut to Junk by Fitch".

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.